Cover Image
Market Research Report

Hemodialysis Market - Growth, Trends, and Forecast (2020 - 2025)

Published by Mordor Intelligence LLP Product code 921279
Published Content info 112 Pages
Delivery time: 2-3 business days
Back to Top
Hemodialysis Market - Growth, Trends, and Forecast (2020 - 2025)
Published: January 1, 2020 Content info: 112 Pages

Market Overview

The major factors for the growth of the hemodialysis market include the rising number of end-stage renal disease (ESRD) patients and the increasing incidence of diabetes and hypertension.

The rise in the number of ESRD and shortage in the availability of kidneys for transplant expected to boost the growth of the market. Chronic kidney disease (CKD) is a condition that causes reduced kidney function over a period of time. It may develop over many years and lead to end-stage kidney (or renal) disease (ESRD). It has become an enormous public health issue that continues to rise. As per the estimation by the Global Burden of Disease Study, kidney disease was the 12th-most common cause of death, accounting for 1.1 million deaths worldwide in 2015. Furthermore, as per the 2016 report on Diabetes and Chronic Kidney Disease, diabetes causes 44% of all new cases of kidney failure. Thus, owing to the rising burden of kidney failures there will be a huge demand for hemodialysis equipment resulting in high growth of the market.

Scope of the Report

As per the scope of this report, hemodialysis is a process of purifying the blood of a person whose kidneys are not working normally. The market covers various equipment and consumables that are used for hemodialysis. The market is segmented by product type, modality, and geography.

Key Market Trends

Conventional Long-Term Hemodialysis is the Segment by Modality expected to Hold Largest Market Share over the Forecast Period

The hemodialysis market is segmented by Modality in three major segments Conventional Long-Term Hemodialysis, Short Daily Hemodialysis, and Nocturnal hemodialysis. The Conventional Long-Term Hemodialysis is expected to hold a large market share owing to the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients. According to the Organ Procurement and Transplantation Network around 83.7% of people are waiting for kidney transplants. Thus, owing to the shortage of kidneys for transplant the market is expected to witness high growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

The United States is expected to be the largest market for hemodialysis owing to the presence of better healthcare infrastructure and the presence of major market players. As per the National Institute of Diabetes and Digestive and Kidney Disease, the prevalence of Chronic Kidney Disease (CKD) in the United States is about 14%. The prevalence of CKD is approximately 32% in the population above age 60 years, which occupies more than 15% of the US population. Also, there are currently 121,678 people waiting for lifesaving organ transplants in the United States of these, 100,791 await kidney transplants. Thus, considering all the above-mentioned factors the market is expected to witness high growth.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of a few market players. Some of the market players are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cantel Medical Corp., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic PLC, Nipro Corporation, and NxStage Medical, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support
Table of Contents
Product Code: 67144

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Number of End Stage Renal Disease Patients
    • 4.2.2 Increasing Incidence of Diabetes and Hypertension
  • 4.3 Market Restraints
    • 4.3.1 Risks and Complications associated with Dialysis
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product Type
    • 5.1.1 Equipment
      • Dialysis Machines
      • Hemodialysis Water Treatment Systems
      • Others hemodialysis equipment
    • 5.1.2 Consumables
      • Dialyzers
      • Catheters
      • Other hemodialysis consumables
  • 5.2 By Modality
    • 5.2.1 Conventional Long-Term Hemodialysis
    • 5.2.2 Short Daily Hemodialysis
    • 5.2.3 Nocturnal hemodialysis
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Asahi Kasei Corporation
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Baxter International Inc.
    • 6.1.4 Becton, Dickinson and Company
    • 6.1.5 Cantel Medical Corp.
    • 6.1.6 DaVita Inc.
    • 6.1.7 Fresenius Medical Care AG & Co. KGaA
    • 6.1.8 Medtronic PLC
    • 6.1.9 Nipro Corporation
    • 6.1.10 NxStage Medical, Inc.


Back to Top